50microgrammatrixmadjuvant
chief executive officer novavax
chief executive officer sk bioscience
coronavirus spike s protein
country: unknown
novavax' recombinant nanoparticle technology
protein based vaccine candidate
saponin based matrixmadjuvant
stanley c erck president
two pivotal phase 3 trials